Company news

OPKO Health, Inc. news in 2024

OPKO Health, Inc.'s news releases, calls and decks from 2024, newest first.

View company

OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

November 19, 2024

OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

November 6, 2024

OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

October 28, 2024

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

October 6, 2024

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders

September 24, 2024

OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development

September 22, 2024

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

September 15, 2024

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

August 6, 2024

OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024

July 31, 2024

OPKO Health Announces $100 Million Share Repurchase Program

July 17, 2024

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments

July 16, 2024

OPKO Health to Participate in the Jefferies Global Healthcare Conference

May 30, 2024

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

May 6, 2024

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

May 2, 2024

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

February 26, 2024

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

February 21, 2024

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes

January 8, 2024

OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 7, 2024

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

January 3, 2024

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

January 2, 2024

Calls in 2024

Decks in 2024